Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Cimetidine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cimetidine and what is the scope of cimetidine patent protection?

is the generic ingredient in seven branded drugs marketed by Sandoz, Ivax Sub Teva Pharms, Upsher-smith Labs, Watson Labs Inc, Glaxosmithkline, Sandoz Inc, Watson Labs, Chartwell Molecules, Medtech Products, Dava Pharms Inc, Mylan, Apotex, Teva, Contract Pharmacal, Cycle Pharms Ltd, Pliva, Perrigo, L Perrigo Co, Vintage Pharms Llc, Ani Pharms Inc, Hospira, Teva Parenteral, Luitpold, Pharm Assoc, Wockhardt, Apotex Inc, Hi Tech Pharma, and G And W Labs Inc, and is included in fifty-six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for cimetidine. Thirty-five suppliers are listed for this compound.

Summary for Generic Name: cimetidine

Drug Master File Entries: see list25
Suppliers / Packagers: see list35
Bulk Api Vendors: see list91
Clinical Trials: see list21
Patent Applications: see list7,570
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cimetidine at DailyMed

Pharmacology for Ingredient: cimetidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medtech Products
TABLET;ORAL020238-002Aug 21, 1996OTCYesYes► Subscribe► Subscribe
Sandoz Inc
TABLET;ORAL075122-001Jun 19, 1998DISCNNoNo► Subscribe► Subscribe
Medtech Products
TABLET;ORAL020238-001Jun 19, 1995DISCNYesNo► Subscribe► Subscribe
TABLET;ORAL074100-004Jan 31, 1995DISCNNoNo► Subscribe► Subscribe
Ivax Sub Teva Pharms
TABLET;ORAL074424-002Jul 28, 1995DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus